Table 4.
Occurrence of lumbopelvic pain and the respective pain scores of the intervention and control group
| Prevalence of pain | BPP group N (%) | Control group N (%) | RR (95%CI) | n |
|---|---|---|---|---|
|
Lumbar pain |
|
|
|
|
| Baseline |
57 (58.8) |
65 (65.0) |
0.90 (0.73–1.13) |
197 |
| Intermediate evaluation |
53 (59.6) |
47 (63.5) |
0.94 (0.74–1.20) |
164 |
| Final evaluation |
54 (63.5) |
48 (63.2) |
1.01 (0.79–1.27) |
161 |
|
Pelvic pain) |
|
|
|
|
| Baseline |
14 (14.4) |
15 (15.0) |
0.96 (0.49–1.89) |
197 |
| Intermediate evaluation |
24 (27.0) |
15 (20.3) |
1.33 (0.75–1.34) |
164 |
| Final evaluation |
24 (28.2) |
21 (27.6) |
1.02 (0.62–1.68) |
161 |
|
Intensity of pain |
VAS (cm) |
VAS (cm) |
Mean difference (95% CI) |
|
|
Lumbar pain (mean±sd) |
|
|
|
|
| Baseline |
4.7 ± 2.7 |
4.5 ± 2.2 |
0.23 (-0.64–1.09) |
122 |
| Intermediate evaluation |
5.1 ± 2.3 |
5.1 ± 2.5 |
0.08 (-0.86–1.03) |
99 |
| Final evaluation |
5.1 ± 2.3 |
4.8 ± 2.5 |
0.34 (-0.61–1.28) |
102 |
|
Pelvic pain (mean±sd) |
|
|
|
|
| Baseline |
3.8 ± 2.1 |
4.7 ± 2.4 |
-0.9 (-2.49–0.78) |
29 |
| Intermediate evaluation |
4.9 ± 2.7 |
5.4 ± 2.3 |
-0.47 (-2.12–1.19) |
39 |
| Final evaluation | 5.5 ± 2.9 | 5.9 ± 2.8 | -0.38 (-2.09–1.33) | 44 |